Literature DB >> 7305917

Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.

R B Sim, E Sim.   

Abstract

The alpha polypeptide chain of the complement protein C3 splits into two fragments of 74 000 and 46 000 apparent mol.wt. under certain conditions used to prepare the protein for SDS (sodium dodecyl sulphate)/polyacrylamide-gel electrophoresis. The cleavage reaction occurs over a wide range of temperatures and from pH 4.6 to 10.6 in the presence of denaturants such as urea, SDS and guanidine hydrochloride. It is also induced by heat-denaturation of C3 in the absence of chemical denaturants. The reaction occurs only with haemolytically active C3, and is not observed with hydroxylamine-inactivated C3 or with C3b. A similar cleavage of the alpha-chain of complement component C4 occurs under the same conditions, forming fragments of 53 000 and 41 000 apparent mol.wt. This reaction is again specific for haemolytically active C4, and does not occur with C4b or hydroxylamine-inactivated C4. The complement component C5, although structurally similar to C3 and C4, does not undergo a reaction of this type. The characteristics of the denaturation-induced cleavage of C3 and C4 match those described for the 'heat-induced' cleavage of alpha 2-macroglobulin [Harpel, Hayes & Hugli (1979) J. Biol. Chem. 254, 8669-8678]. Cleavage of alpha 2-macroglobulin is also specific for the active form of the protein, and does not occur with chemically inactivated or proteinase-cleaved forms. The unusual conditions and specificity of the peptide-bond cleavage in all three proteins suggest that it is an autolytic process rather than being the result of trace proteinase contamination. The active forms of C3, C4 and alpha 2-macroglobulin have the transient ability to form covalent bonds after activation. The autolytic cleavage reaction is likely to be related to the covalent-bond-forming reactions of these proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305917      PMCID: PMC1162584          DOI: 10.1042/bj1930129

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

Review 3.  Activation of the complement system by antibody-antigen complexes: the classical pathway.

Authors:  R R Porter; K B Reid
Journal:  Adv Protein Chem       Date:  1979

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.

Authors:  J W Goers; R R Porter
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

6.  Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

7.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

8.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

9.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  37 in total

1.  A highly unusual thioester bond in a pilus adhesin is required for efficient host cell interaction.

Authors:  Jonathan A Pointon; Wendy D Smith; Gerhard Saalbach; Allister Crow; Michael A Kehoe; Mark J Banfield
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

2.  EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5.

Authors:  Dorothea Orth; Silvia Ehrlenbach; Jens Brockmeyer; Abdul Basit Khan; Georg Huber; Helge Karch; Bettina Sarg; Herbert Lindner; Reinhard Würzner
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 3.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

4.  Purification and characterization of a tetrameric alpha-macroglobulin proteinase inhibitor from the gastropod mollusc Biomphalaria glabrata.

Authors:  R C Bender; C J Bayne
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

5.  Phenotyping of human complement component C4, a class-III HLA antigen.

Authors:  E Sim; S J Cross
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

6.  Limulus alpha 2-macroglobulin. First evidence in an invertebrate for a protein containing an internal thiol ester bond.

Authors:  P B Armstrong; J P Quigley
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

7.  Common evolutionary origin of alpha 2-macroglobulin and complement components C3 and C4.

Authors:  L Sottrup-Jensen; T M Stepanik; T Kristensen; P B Lønblad; C M Jones; D M Wierzbicki; S Magnusson; H Domdey; R A Wetsel; A Lundwall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Sequence determination of the thiolester site of the fourth component of human complement.

Authors:  R A Harrison; M L Thomas; B F Tack
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Characterization of the Mr difference between secreted murine fourth component of complement and the major plasma form: evidence for carboxyl-terminal cleavage of the alpha chain.

Authors:  D R Karp; D C Shreffler; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

10.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.